On June 3, 2022, Andrew Forman, Deputy Assistant Attorney General of the United States Department of Justice Antitrust Division (DOJ) publicly stated that the DOJ is considering “enhancing antitrust enforcement around a...more
6/22/2022
/ Acquisitions ,
Antitrust Division ,
Department of Justice (DOJ) ,
Executive Orders ,
Federal Trade Commission (FTC) ,
Healthcare ,
Home Health Care ,
Joe Biden ,
Monopolization ,
Pharmaceutical Industry ,
Popular ,
Premerger Notifications ,
Private Equity
Throughout the first half of 2020, much of the world has grappled with the reality of the coronavirus (COVID-19) pandemic, as the outbreak spread rapidly across entire countries and shut down large segments of the global...more
7/7/2020
/ ACPERA ,
Antitrust Provisions ,
Coronavirus/COVID-19 ,
Department of Justice (DOJ) ,
DPA ,
Pharmaceutical Industry ,
Price-Fixing ,
Remote Working ,
UK ,
UK Competition and Markets Authority (CMA) ,
Whistleblower Protection Policies